DE19952410A1 - Solid lipid nanoparticles containing a UV filter material are useful in aqueous dispersion form as high filter content sunscreen compositions - Google Patents
Solid lipid nanoparticles containing a UV filter material are useful in aqueous dispersion form as high filter content sunscreen compositionsInfo
- Publication number
- DE19952410A1 DE19952410A1 DE1999152410 DE19952410A DE19952410A1 DE 19952410 A1 DE19952410 A1 DE 19952410A1 DE 1999152410 DE1999152410 DE 1999152410 DE 19952410 A DE19952410 A DE 19952410A DE 19952410 A1 DE19952410 A1 DE 19952410A1
- Authority
- DE
- Germany
- Prior art keywords
- lipid nanoparticles
- filter
- solid lipid
- solid
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004904 UV filter Substances 0.000 claims abstract description 30
- 239000002105 nanoparticle Substances 0.000 claims abstract description 16
- 239000002047 solid lipid nanoparticle Substances 0.000 claims abstract description 16
- 239000006185 dispersion Substances 0.000 claims abstract description 14
- 239000000126 substance Substances 0.000 claims description 29
- 238000002360 preparation method Methods 0.000 claims description 23
- 230000000475 sunscreen effect Effects 0.000 claims description 22
- 239000000516 sunscreening agent Substances 0.000 claims description 22
- 150000002632 lipids Chemical class 0.000 claims description 20
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 9
- 238000000265 homogenisation Methods 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 claims description 3
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 20
- 239000000839 emulsion Substances 0.000 description 12
- 239000007787 solid Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 235000004866 D-panthenol Nutrition 0.000 description 2
- 239000011703 D-panthenol Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 239000003581 cosmetic carrier Substances 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 229960003949 dexpanthenol Drugs 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000007908 nanoemulsion Substances 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 230000037338 UVA radiation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229940075510 carbopol 981 Drugs 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000006070 nanosuspension Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/652—The particulate/core comprising organic material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nanotechnology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Die Erfindung betrifft Lichtschutzzubereitungen mit einem Gehalt an festen Lipidnano partikeln, die mindestens einen UV-Filter umfassen.The invention relates to sunscreens with a content of solid Lipidnano particles comprising at least one UV filter.
Die schädigende Wirkung des ultravioletten Teils der Sonnenstrahlung auf die Haut ist seit langem bekannt. Zum Schutz der Haut sowohl vor UVA-Strahlung als auch vor UVB- Strahlung sind zahlreiche chemische und physikalische Filtersubstanzen entwickelt wor den, die die Wirkung der Sonnenstrahlen abschwächen.The damaging effect of the ultraviolet part of solar radiation on the skin has been going on long known. To protect the skin against both UVA radiation and UVB Radiation has developed numerous chemical and physical filter substances wor those that weaken the effect of the sun's rays.
Durch chemische Lichtschutzfilter wird die auf die Haut auftreffende UV-Strahlung in Wärmeenergie umgewandelt. Chemische Lichtschutzfilter können sowohl lipophile als auch hydrophile Eigenschaften aufweisen, und entsprechend dieser Eigenschaften unter scheidet man zwischen öllöslichen und wasserlöslichen Filtern. Zur Bildung einer Licht schutzzubereitung werden UV-Filtersubstanzen üblicherweise in kosmetische Träger ein gearbeitet und in Form von Lotionen, Cremes, Salben und dergleichen formuliert. Derarti ge Formulierungen basieren zumeist auf Emulsionen. Emulsionen sind im weiteren Sinne disperse, mehr oder weniger dickflüssige Zubereitungen, die aus zwei oder mehreren inein ander nicht löslichen Flüssigkeiten bestehen, von denen eine wäßrig ist. Liegen zwei mit einander nicht mischbare Flüssigkeiten vor und handelt es sich um einfache Emulsions systeme, kann man grundsätzlich zwei Grundtypen von Emulsionen unterscheiden: Öl-in- Wasser-Emulsionen (O/W-Emulsionen) und Wasser-in-Öl-Emulsionen (W/O-Emulsio nen). In Abhängigkeit von ihrer Hydrophilie werden die Filtersubstanzen in verschiedener Art und Weise in den kosmetischen Träger eingearbeitet. Wasserlösliche Filter werden in die Wasserphase eines Emulsionssystems und ölige oder öllösliche Filter in die Lipidphase eines Emulsionssystems eingearbeitet. Problematisch bei dieser Einarbeitung ist die oft mals schlechte Löslichkeit der Filtersubstanzen in der Wasser- bzw. Ölphase des Emul sionssystems. Dies gilt insbesondere für die sehr häufig verwendeten festen organischen UV-Filtersubstanzen. Aufgrund ihrer schlechten Löslichkeit in den üblicherweise verwen deten Trägermedien können diese UV-Filtersubstanzen nur in relativ geringen Mengen eingesetzt werden. Da nun aber der erreichbare Lichtschutzfaktor einer Lichtschutzzube reitung von der Menge der in ihr enthaltenen UV-Filter abhängig ist, ist es wünschenswert, möglichst hohe Konzentrationen auch dieser festen organischen Lichtschutzfilter in Licht schutzzubereitungen zu realisieren.Through chemical sunscreen, the impact on the skin UV radiation in Heat energy converted. Chemical sunscreens can be lipophilic as well also have hydrophilic properties, and according to these properties under one separates between oil-soluble and water-soluble filters. To form a light protection preparation UV filter substances are usually in cosmetic carriers worked and formulated in the form of lotions, creams, ointments and the like. Derarti Most formulations are based on emulsions. Emulsions are in the broader sense disperse, more or less viscous preparations consisting of two or more other non-soluble liquids, one of which is aqueous. Lying with two are immiscible liquids and are simple emulsions systems, you can basically differentiate between two basic types of emulsions: oil-in- Water emulsions (O / W emulsions) and water-in-oil emulsions (W / O Emulsio NEN). Depending on their hydrophilicity, the filter substances in different Fashion incorporated into the cosmetic vehicle. Water-soluble filters are in the water phase of an emulsion system and oily or oil-soluble filters in the lipid phase incorporated an emulsion system. The problem with this training is often poor solubility of the filter substances in the water or oil phase of the emulsifier sion system. This is especially true for the very commonly used solid organic UV filter substances. Because of their poor solubility in the commonly used Deten carrier media, these UV filter substances only in relatively small amounts be used. But now the achievable SPF of a Lichtschutzzube depends on the amount of UV filters it contains, it is desirable to highest possible concentrations of these solid organic sunscreen filters in light to realize protective preparations.
Es wurden bereits verschiedene Anstrengungen unternommen, um die Löslichkeit fester organischer Lichtschutzfilter zu erhöhen. So wird in der PCT-Anmeldung WO 97/25020 beschrieben, daß die Löslichkeit des Filters Uvinul T150 (zu beziehen von der BASF Aktiengesellschaft) durch Zusatz von verzweigten und/oder unverzweigten Carbonsäuren mit Kettenlängen von 10 bis 24 Kohlenstoffatomen, die zumindest 10% in protonierter Form vorliegen, erhöht werden kann.Various efforts have been made to increase solubility increase organic sunscreen. Thus, in PCT application WO 97/25020 described that the solubility of the filter Uvinul T150 (available from BASF Aktiengesellschaft) by adding branched and / or unbranched carboxylic acids having chain lengths of 10 to 24 carbon atoms which are at least 10% protonated Form can be increased.
In der WO 95/22959 werden Lichtschutzzubereitungen beschrieben, die unlösliche Licht schutzfilter in fester mikronisierter Form enthalten. Die Mikronisierung der Filtersub stanzen erfordert aufwendige Mahlverfahren. Die durch diese Mahlverfahren erhaltenen mikronisierten Filter lassen sich nur unter Zusatz von Emulgatoren in W/O- bzw. O/W- Emulsion einarbeiten.In WO 95/22959 sunscreen preparations are described, the insoluble light protective filter in solid micronized form. Micronization of the filtersub punching requires complex grinding processes. Those obtained by these milling methods micronised filters can only be obtained by adding emulsifiers in W / O or O / W Incorporate emulsion.
Seit einiger Zeit sind neue Trägermaterialien für Arzneistoffe bekannt, die auf sogenannten festen Lipidnanopartikeln (solid lipid nanoparticles, SLN®) basieren, die beispielsweise in der deutschen Offenlegungsschrift DE 44 40 337 beschrieben werden. Feste Lipidnanopar tikel sind Partikel mit einer mittleren Partikelgröße im Nanometerbereich, d. h. ca. 80 nm bis ca. 1000 nm. Sie bestehen aus einem festen Lipid, das in wäßriger Dispersion mit einem Tensid oder Polymer stabilisiert ist. Die Herstellung der festen Lipidnanopartikel erfolgt entweder durch Hochdruckhomogenisation von Lipiden im geschmolzenen Zustand (Heißhomogenisation) oder im festen Aggregatzustand (Kalthomogenisation). Bei der Heißhomogenisation wird der Wirkstoff im geschmolzenen Lipid gelöst, die geschmolzene Lipid-Wirkstofflösung in eine heiße Tensidlösung mit einer Temperatur, die ca. 5°C höher ist als der Schmelzpunkt des Lipids gegossen und mit einem Rührer eine Rohemulsion hergestellt, die anschließend bei ca. 500 bar hochdruckhomogenisert wird. Nach Abkühlen der erhaltenen Nanoemulsion bilden sich feste Lipidnanopartikel. Bei der Kalthomogenisa tion wird die Lipid-Wirkstoffschmelze abgekühlt, das erstarrte Lipid zu Mikropartikeln ge mahlen, die dann in kalter Tensidlösung suspendiert werden. Die erhaltene Mikropartikel suspension wird dann im festen Zustand homogenisiert, wobei die Scher- und Graviations kräfte ausreichend hoch sind, um die Mikropartikel im festen Aggregatzustand zu feinen Lipidnanopartikeln zu zerkleinern. Als Produkt wird direkt eine wäßrige Dispersion fester Lipidnanopartikel erhalten.For some time, new carrier materials for drugs, known as so-called solid lipid nanoparticles (SLN®) based, for example, in German Offenlegungsschrift DE 44 40 337 are described. Solid lipid nanopar Particles are particles with a mean particle size in the nanometer range, d. H. about 80 nm to about 1000 nm. They consist of a solid lipid, which in aqueous dispersion with a surfactant or polymer is stabilized. The preparation of solid lipid nanoparticles occurs either by high-pressure homogenization of lipids in the molten state (Hot homogenization) or in the solid state (cold homogenization). In the Hot homogenization dissolves the active ingredient in the molten lipid, which is melted Lipid drug solution in a hot surfactant solution with a temperature that is about 5 ° C higher is poured as the melting point of the lipid and a crude emulsion with a stirrer produced, which is then high pressure homogenized at about 500 bar. After cooling The obtained nanoemulsion form solid lipid nanoparticles. At the Kalthomogenisa tion, the lipid active ingredient melt is cooled, the solidified lipid ge to microparticles ge grind, which are then suspended in cold surfactant solution. The obtained microparticles suspension is then homogenized in the solid state, with the shear and graviations forces are high enough to fine microparticles in the solid state To break up lipid nanoparticles. The product is directly an aqueous dispersion solid Obtained lipid nanoparticles.
Aufgabe der vorliegenden Erfindung ist es, neuartige Lichtschutzzubereitungen anzugeben, die bei guter Hautverträglichkeit einen erhöhten Lichtschutzfaktor aufweisen bzw. einen gegenüber vorbekannten Lichtschutzzubereitungen erhöhten Gehalt an UV-Filtersubstan zen haben.The object of the present invention is to provide novel sunscreen preparations, which have a high SPF with good skin tolerance or a compared to previously known sunscreen preparations increased content of UV Filterubstan zen.
Diese Aufgabe wird mittels der im unabhängigen Anspruch definierten Lichtschutzzube reitung gelöst. This object is achieved by means of the light protection tube defined in the independent claim solved.
Die abhängigen Ansprüche definieren vorteilhafte Ausführungsformen der Erfindung.The dependent claims define advantageous embodiments of the invention.
In den der vorliegenden Erfindung zugrundeliegenden Untersuchungen wurde über raschend gefunden, daß die für den Bereich der Arzneistoffe bereits beschriebenen Träger substanzen basierend auf festen Lipidnanopartikeln auch als Träger für UV-Filtersubstan zen und somit zur Herstellung von Lichtschutzzubereitungen verwendet werden können, die sich durch einen besonders hohen Gehalt an UV-Filtersubstanzen und damit einen hohen Lichtschutzfaktor auszeichnen.In the underlying of the present invention studies has been surprisingly found that the already described for the field of drugs carrier substances based on solid lipid nanoparticles also as a carrier for UV filter zen and thus can be used for the production of sunscreen preparations, characterized by a particularly high content of UV filter substances and thus a high sun protection factor.
Gemäß einer Ausführungsform der vorliegenden Erfindung werden bei Raumtemperatur feste öllösliche Filter gemäß der an sich bekannten Technologie zur Herstellung von festen Lipidnanopartikeln in einer geschmolzenen Lipidphase gelöst und nach Einbringen der Schmelze in eine wäßrige Lösung eines Tensids hochdruckhomogenisiert. Beim Abkühlen erstarrt die in Nanotröpfchen vorliegende Lipidphase, wodurch sich der Filter in fester Lö sung befindet.According to one embodiment of the present invention, at room temperature solid oil-soluble filters according to the per se known technology for the production of solid Lipid nanoparticles dissolved in a molten lipid phase and after introduction of the Melt high pressure homogenized in an aqueous solution of a surfactant. On cooling The lipid phase, which is present in nanodroplets, solidifies, as a result of which the filter is solidified is located.
Alternativ und besonders bevorzugt kann aber auch die Filtersubstanz selbst als die zur Herstellung von festen Lipidnanopartikeln dienende Lipidphase verwendet werden. Gemäß dieser Ausführungsform der vorliegenden Erfindung wird die UV-Filtersubstanz aufge schmolzen, in einer wäßrigen, mindestens ein Tensid umfassend Phase dispergiert und hochdruckhomogenisiert. Nach dem Erkaltenlassen liegt der feste UV-Filter in Nanopar tikelform entweder kristallin oder bei Verwendung geeigneter Kristallisationsinhibitoren, wie z. B. Gelatine PVP oder sonstiger Polymere, in amorpher Form vor.Alternatively and particularly preferably, however, the filter substance itself may be used as the Production of solid lipid nanoparticles serving lipid phase can be used. According to In this embodiment of the present invention, the UV filter substance is applied melted, dispersed in an aqueous, at least one surfactant comprising phase and high pressure homogenization. After cooling, the solid UV filter is in Nanopar form either crystalline or using suitable crystallization inhibitors, such as As gelatin PVP or other polymers, in an amorphous form.
Die gemäß diesen beiden alternativen Verfahren der vorliegenden Erfindung hergestellten UV-Filtersubstanzen enthaltenden Nanopartikel können in übliche kosmetische Träger systeme, wie beispielsweise O/W-Cremes oder -Emulsionen, W/O-Cremes oder -Lotionen oder Hydrodispersionsgele, eingearbeitet werden. Die gebildete Nanodispersion kann besonders vorteilhaft aber auch direkt als dünnflüssige wäßrige Zubereitung als Spray auf die Haut aufgebracht werden. Die erfindungsgemäß hergestellten Lichtschutzzubereitun gen zeigen im Vergleich zu herkömmlichen Sonnenschutzmitteln bei gleichen Konzentra tionen an UV-Filtersubstanzen einen mindestens um den Faktor 2 bis 4 erhöhten Licht schutzfaktor. Weitere Vorteile der erfindungsgemäßen Lichtschutzzubereitungen, die ver mutlich darauf beruhen, daß die Filtersubstanzen in einer Fettmatrix eingeschlossen sind, sind eine erhöhte Wasserfestigkeit, eine geringere Hautpenetration, woraus eine verbes serte Verträglichkeit der erfindungsgemäßen Zubereitungen resultiert, sowie eine erhöhte Fotostabilität der UV-Filtersubstanzen.Those prepared according to these two alternative methods of the present invention Nanoparticles containing UV filter substances can be converted into customary cosmetic carriers systems, such as O / W creams or emulsions, W / O creams or lotions or hydrodispersion gels. The formed nanodispersion can particularly advantageous but also directly as a thin aqueous preparation as a spray on the skin will be applied. The sunscreen preparation prepared according to the invention gene show at the same Konzentra compared to conventional sunscreens tions on UV filter substances increased by at least a factor of 2 to 4 light protection factor. Further advantages of the sunscreen preparations according to the invention, the ver probably based on the fact that the filter substances are enclosed in a fat matrix, are an increased water resistance, a lower skin penetration, resulting in a verbes Sert compatibility of the preparations according to the invention results, as well as an increased Photostability of UV filter substances.
Die Herstellung der erfindungsgemäßen Lichtschutzzubereitungen ist an sich unproblema tisch und erfolgt gemäß den bereits bekannten Vorschriften zur Herstellung von Nano suspensionen fester Lipidnanopartikel; verwiesen sei beispielhaft auf die in der DE OS 44 40 337 offenbarten Verfahren. Die zur Herstellung der erfindungsgemäßen UV-Filter ent haltenden Nanopartikel verwendete Lipidphase kann, wie oben ausgeführt, entweder aus der Filtersubstanz selber bestehen oder aber durch übliche Lipide, wie beispielsweise Cetylpalmitat, Bienenwachs oder Tristearin gebildet werden. Die zur Bildung der festen Lipidnanopartikel verwendeten Tenside sind erfindungsgemäß vorzugsweise Substanzen, die eine gute Hautverträglichkeit zeigen. Besonders bevorzugt ist die Verwendung von Cholesterol, Lecithin oder Methylglucosiden, wie beispielsweise solchen aus der Tego- Care®-Reihe. Neben den in den Lipinanopartikeln enthaltenen UV-Filtern können die erfindungsgemäßen Zubereitungen weitere UV-Filtersubstanzen, insbesondere auch physikalische Filtersubstanzen, enthalten.The preparation of the sunscreen preparations according to the invention is in itself unproblema Table and carried out according to the already known regulations for the production of nano suspensions of solid lipid nanoparticles; Reference is made by way of example to those in DE OS 44 40,337 disclosed methods. The ent for the production of UV filters according to the invention lipid phase used, as stated above, either from consist of the filter substance itself or by conventional lipids, such as Cetyl palmitate, beeswax or tristearin are formed. The formation of the solid Lipid nanoparticles used surfactants are according to the invention preferably substances, which show a good skin compatibility. Particularly preferred is the use of Cholesterol, lecithin or methylglucosides, such as those from the Tego- Care® series. In addition to the UV filters contained in the lipinanoparticles, the preparations according to the invention further UV filter substances, in particular also physical filter substances contained.
Die erfindungsgemäßen Nanopartikeldispersionen umfassen bevorzugt 0,1 bis 50 Gew.-% Nanopartikel. Der Gehalt der erfindungsgemäßen Nanopartikel an UV-Filtersubstanz liegt zwischen 0,1 und 100 Gew.-%. Der Gehalt der Nanodispersion in den erfindungsgemäßen Lichtschutzzubereitungen liegt zwischen 0,1 und 100 Gew.-%.The nanoparticle dispersions according to the invention preferably comprise 0.1 to 50% by weight. Nanoparticles. The content of the nanoparticles according to the invention on UV filter substance is between 0.1 and 100% by weight. The content of the nanodispersion in the inventive Sunscreen preparations are between 0.1 and 100 wt .-%.
Die folgenden Beispiele verdeutlichen die Erfindung, ohne sie zu beschränken. The following examples illustrate the invention without limiting it.
Es wird eine UV-Filtersubstanz enthaltende Nanopartikelsuspension folgender Zusam
mensetzung hergestellt:
A nanoparticle suspension containing UV filter substance is prepared according to the following composition:
Der UV-Filter Uvinul T150 (2,4,6-Trianilino-p-(carbo-2'-ethyl-hexyl-1'oxy)1,3,5-triazin) wurde aufgeschmolzen und in eine wäßrige Lösung von Cholesterol und Tego Care® ein gebracht, die eine Temperatur von ca. 5°C oberhalb der Schmelztemperatur des UV-Fil ters hatte. Die erhaltene Emulsion wird in einem Hochdruckhomogenisator zu Nanopar tikeln dispergiert und die erhaltene Nanoemulsion dann abgekühlt. Dann werden Glycerol und Ethanol zugesetzt. Die so erhaltene Nanopartikeldispersion kann direkt als Spray auf die Haut aufgebracht werden.Uvinul T150 UV filter (2,4,6-trianilino-p- (carbo-2'-ethyl-hexyl-1'-oxy) 1,3,5-triazine) was melted and immersed in an aqueous solution of cholesterol and Tego Care® brought about a temperature of about 5 ° C above the melting temperature of the UV-fil ters had. The resulting emulsion is Nanopar in a high pressure homogenizer dispersed particles and the resulting nanoemulsion then cooled. Then glycerol and ethanol added. The nanoparticle dispersion thus obtained can be applied directly as a spray the skin will be applied.
Es wurden Nanopartikeldispersionen gemäß Beispiel 1 hergestellt, bei denen anstelle des UV-Filters Uvinul T150 die UV-Filter UVA Sorb HEB oder Eusolex 6300 und/oder Parsol 1789 verwendet wurden. Nanoparticle dispersions according to Example 1 were prepared in which instead of the UV filters Uvinul T150 the UV filters UVA Sorb HEB or Eusolex 6300 and / or Parsol 1789 were used.
Es wird eine Nanopartikeldispersion folgender Zusammensetzung hergestellt:
A nanoparticle dispersion of the following composition is prepared:
Zunächst wurde eine Schmelze aus Tristearin und Uvinul T150 gebildet, die in eine Lö sung von Tego Care® und Lecithin eingebracht wurde, die eine Temperatur von ca. 5°C oberhalb der Temperatur der Schmelze hatte. Wie zuvor in Beispiel 1 beschrieben wird durch Hochdruckhomogenisation eine Nanodispersion gebildet. Nach Abkühlung der erhaltenen Dispersion wird Glycerol zugesetzt. Die so erhaltene Dispersion kann direkt in Form eines Sprays auf die Haut aufgebracht werden.First, a melt of tristearin and Uvinul T150 was formed, which in a Lö Tego Care® and lecithin, which has a temperature of about 5 ° C above the temperature of the melt. As previously described in Example 1 formed by high-pressure homogenization, a nanodispersion. After cooling the Glycerol is added to the resulting dispersion. The dispersion thus obtained can be directly in Form of a spray can be applied to the skin.
Entsprechend Beispiel 3 wurden Nanopartikeldispersionen hergestellt, bei denen anstelle des Uvinul T150 die UV-Filter UVA Sorb HEB oder Eusolex 6300 oder Parsol 1789 verwendet wurden. According to Example 3, nanoparticle dispersions were prepared in which instead of of the Uvinul T150 the UV filters UVA Sorb HEB or Eusolex 6300 or Parsol 1789 were used.
Es wird eine Öl-in-Wasser-Emulsion folgender Zusammensetzung hergestellt:
An oil-in-water emulsion of the following composition is prepared:
Es wird eine Wasser-in-Öl-Lotion folgender Zusammensetzung hergestellt:
A water-in-oil lotion of the following composition is produced:
Es wird ein Hydrodispersionsgel folgender Zusammensetzung hergestellt:
A hydrodispersion gel of the following composition is prepared:
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1999152410 DE19952410B4 (en) | 1999-10-29 | 1999-10-29 | Sunscreen preparations comprising solid lipid nanoparticles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1999152410 DE19952410B4 (en) | 1999-10-29 | 1999-10-29 | Sunscreen preparations comprising solid lipid nanoparticles |
Publications (2)
Publication Number | Publication Date |
---|---|
DE19952410A1 true DE19952410A1 (en) | 2001-05-17 |
DE19952410B4 DE19952410B4 (en) | 2007-03-29 |
Family
ID=7927465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1999152410 Expired - Lifetime DE19952410B4 (en) | 1999-10-29 | 1999-10-29 | Sunscreen preparations comprising solid lipid nanoparticles |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE19952410B4 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2827510A1 (en) * | 2001-07-18 | 2003-01-24 | Oreal | New insoluble aryl vinyl ketones presented in the form of very fine particles are used as ultraviolet radiation filters in cosmetic compositions for the sun protection of skin and hair |
EP1378231A1 (en) * | 2002-06-17 | 2004-01-07 | Ciba Specialty Chemicals Holding Inc. | Formulation of UV absorbers by incorporation in solid lipid nanoparticles |
US7147841B2 (en) | 2002-06-17 | 2006-12-12 | Ciba Specialty Chemicals Corporation | Formulation of UV absorbers by incorporation in solid lipid nanoparticles |
WO2007042259A1 (en) * | 2005-10-14 | 2007-04-19 | Unilever Plc | Stable sunscreen composition |
DE102007025452A1 (en) | 2007-05-31 | 2008-12-04 | Ernst-Moritz-Arndt-Universität Greifswald | Surface coating method for precipitating layers onto e.g., medical appliances, involves pre-treating surface with plasma process before applying micro- or nano-particles and then fixing |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19537415A1 (en) * | 1995-10-09 | 1997-04-10 | New Standard Gmbh | Use of drop-like vesicles to compartmentalise active components |
EP0852941A1 (en) * | 1996-12-13 | 1998-07-15 | Vesifact Ag | Nanodispersion cosmetic composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996037192A1 (en) * | 1995-05-26 | 1996-11-28 | Vesifact Ag | Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids |
-
1999
- 1999-10-29 DE DE1999152410 patent/DE19952410B4/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19537415A1 (en) * | 1995-10-09 | 1997-04-10 | New Standard Gmbh | Use of drop-like vesicles to compartmentalise active components |
EP0852941A1 (en) * | 1996-12-13 | 1998-07-15 | Vesifact Ag | Nanodispersion cosmetic composition |
Non-Patent Citations (1)
Title |
---|
Zülli,F. u. Suter,F.: Preparation and proploertiesof small nanoparticles for skin and hair care. In:SÖFW-Journal, Vol.123, No.13, 1997, S.882-885 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2827510A1 (en) * | 2001-07-18 | 2003-01-24 | Oreal | New insoluble aryl vinyl ketones presented in the form of very fine particles are used as ultraviolet radiation filters in cosmetic compositions for the sun protection of skin and hair |
EP1281391A1 (en) * | 2001-07-18 | 2003-02-05 | L'oreal | Organic insoluble UV filters of the aryl vinylene ketone type and their use in cosmetics |
EP1378231A1 (en) * | 2002-06-17 | 2004-01-07 | Ciba Specialty Chemicals Holding Inc. | Formulation of UV absorbers by incorporation in solid lipid nanoparticles |
US7147841B2 (en) | 2002-06-17 | 2006-12-12 | Ciba Specialty Chemicals Corporation | Formulation of UV absorbers by incorporation in solid lipid nanoparticles |
WO2007042259A1 (en) * | 2005-10-14 | 2007-04-19 | Unilever Plc | Stable sunscreen composition |
DE102007025452A1 (en) | 2007-05-31 | 2008-12-04 | Ernst-Moritz-Arndt-Universität Greifswald | Surface coating method for precipitating layers onto e.g., medical appliances, involves pre-treating surface with plasma process before applying micro- or nano-particles and then fixing |
Also Published As
Publication number | Publication date |
---|---|
DE19952410B4 (en) | 2007-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69500034T2 (en) | Storage-stable, fluid and / or fluidizable cosmetic sunscreens | |
EP0969803B1 (en) | Emulsifier-free finely dispersed systems of the water-in-oil type | |
DE69503933T2 (en) | Cosmetic sunscreens | |
DE3873313T2 (en) | W / OE EMULSION COSMETIC PREPARATIONS. | |
DE60000235T2 (en) | Composition and in particular cosmetic composition containing a sapogenin | |
WO2004075868A1 (en) | O/w emulsifier and o/w emulsions containing potassium cetyl phosphate and method for the production thereof | |
DE19726184A1 (en) | Oil-in-water or multiple emulsion with high concentration of suspended UVB filter | |
EP0845978B1 (en) | Translucent antiperspirants/deodorants | |
DE19842767A1 (en) | Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil type | |
DE3313002A1 (en) | POLYGLYCERIN COMPOUNDS AND CONTAINING COSMETIC PRODUCTS | |
DE69519952T2 (en) | Self-tanning cosmetic products containing dihydroxyacetone | |
EP1641904A2 (en) | O/w emulsifier, o/w emulsion and applications thereof | |
DE4230076A1 (en) | Cosmetic and dermatological sunscreen formulations having an effective cis-urocanic acid content | |
DE19952410B4 (en) | Sunscreen preparations comprising solid lipid nanoparticles | |
DE4443243C2 (en) | Sunscreen preparation with increased SPF | |
EP0813861B1 (en) | Sunscreen compositions in the form of oil-in-water microemulsions | |
DE10027950B4 (en) | Aqueous suspension of nanoparticulate photoprotective filters, process for their preparation and their use and preparations | |
DE19632044A1 (en) | Sun block protective prod. useful for improved phase stability | |
EP3727278A1 (en) | Cosmetic emulsion comprising 1,2-decanediol | |
DE19726121A1 (en) | Oil-in-water or multiple emulsion with high concentration of suspended ultra-violet B filter | |
DE19548014A1 (en) | Cosmetic and dermatological sunscreen formulations in the form of emulsions, in particular O / W macroemulsions, O / W microemulsions or O / W / O emulsions containing solid, dispersed form, oil component sparingly soluble or insoluble UV filter substances | |
DE19820660B4 (en) | Gel-like sunscreen preparations containing oil and water-soluble UV filters | |
DE19632043A1 (en) | Cosmetic products for providing protection against sunlight UV radiation | |
DE19856947B4 (en) | Sunscreens and process for its preparation | |
EP1022017B1 (en) | Cosmetic or pharmaceutical compositions for topical administration with improved stability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Representative=s name: HAMM & WITTKOPP PATENTANWAELTE PARTMBB, DE |
|
R071 | Expiry of right |